Fagron NV Cash Flow Conversion Efficiency
Fagron NV cash flow conversion efficiency. Based on the latest financial reports, Fagron NV (FAGR) has a cash flow conversion efficiency ratio of 0.073x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€43.76 Million ≈ $51.16 Million USD) by net assets (€599.55 Million ≈ $700.94 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see FAGR company net worth for the company's overall valuation and market capitalisation.
Cash Flow Conversion Efficiency of Fagron NV (2004–2025)
Cash flow conversion efficiency of Fagron NV from 2004 to 2025. This chart illustrates how Fagron NV's cash flow conversion efficiency has evolved over time, based on yearly financial data. View FAGR stock price and chart for real-time trading data and today's change.
Fagron NV Cash Flow Conversion Ratio Explained
Fagron NV cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Fagron NV Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Fagron NV ranked by their cash flow conversion efficiency. Review how much free cash does Fagron NV generate to assess how much free cash flow the company generates relative to operating cash flow.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
GPS Participações e Empreendimentos S.A
SA:GGPS3
|
0.039x |
|
B.Grimm Power Public Company Limited
BK:BGRIM
|
0.069x |
|
Friedrich Vorwerk Group SE
F:VH2
|
0.147x |
|
OPmobility SE
PA:OPM
|
0.191x |
|
Airport City Ltd
TA:ARPT
|
0.013x |
|
FLEX LNG Ltd
NYSE:FLNG
|
0.014x |
|
Zhejiang CONBA Pharmaceutical Co Ltd
SHG:600572
|
0.018x |
|
Shenzhen Agricultural Products Co Ltd
SHE:000061
|
0.001x |
Annual Cash Flow Conversion Efficiency for Fagron NV (2004–2025)
The table below shows the annual cash flow conversion efficiency of Fagron NV from 2004 to 2025. Also see FAGR total assets for a full breakdown of the balance sheet.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €556.26 Million ≈ $650.32 Million |
€128.28 Million ≈ $149.97 Million |
0.231x | +6.05% |
| 2024-12-31 | €505.36 Million ≈ $590.82 Million |
€109.89 Million ≈ $128.48 Million |
0.217x | -5.30% |
| 2023-12-31 | €467.63 Million ≈ $546.70 Million |
€107.38 Million ≈ $125.54 Million |
0.230x | -14.28% |
| 2022-12-31 | €408.63 Million ≈ $477.73 Million |
€109.46 Million ≈ $127.97 Million |
0.268x | +11.17% |
| 2021-12-31 | €325.47 Million ≈ $380.50 Million |
€78.42 Million ≈ $91.68 Million |
0.241x | -33.17% |
| 2020-12-31 | €257.82 Million ≈ $301.42 Million |
€92.95 Million ≈ $108.67 Million |
0.361x | +15.13% |
| 2019-12-31 | €246.44 Million ≈ $288.12 Million |
€77.17 Million ≈ $90.23 Million |
0.313x | -10.38% |
| 2018-12-31 | €209.72 Million ≈ $245.18 Million |
€73.28 Million ≈ $85.67 Million |
0.349x | -23.32% |
| 2017-12-31 | €184.88 Million ≈ $216.15 Million |
€84.25 Million ≈ $98.49 Million |
0.456x | +3.20% |
| 2016-12-31 | €152.87 Million ≈ $178.73 Million |
€67.50 Million ≈ $78.92 Million |
0.442x | +139.01% |
| 2015-12-31 | €-64.77 Million ≈ $-75.73 Million |
€73.31 Million ≈ $85.71 Million |
-1.132x | -274.67% |
| 2014-12-31 | €156.94 Million ≈ $183.48 Million |
€101.70 Million ≈ $118.89 Million |
0.648x | +59.40% |
| 2013-12-31 | €155.17 Million ≈ $181.41 Million |
€63.08 Million ≈ $73.74 Million |
0.407x | +47.25% |
| 2012-12-31 | €245.38 Million ≈ $286.88 Million |
€67.74 Million ≈ $79.20 Million |
0.276x | -15.64% |
| 2011-12-31 | €220.45 Million ≈ $257.73 Million |
€72.15 Million ≈ $84.35 Million |
0.327x | +61.69% |
| 2010-12-31 | €208.12 Million ≈ $243.32 Million |
€42.13 Million ≈ $49.25 Million |
0.202x | +0.63% |
| 2009-12-31 | €196.35 Million ≈ $229.56 Million |
€39.50 Million ≈ $46.17 Million |
0.201x | +34.53% |
| 2008-12-31 | €185.53 Million ≈ $216.90 Million |
€27.74 Million ≈ $32.43 Million |
0.150x | -1.67% |
| 2007-12-31 | €178.22 Million ≈ $208.36 Million |
€27.10 Million ≈ $31.68 Million |
0.152x | -17.89% |
| 2006-12-31 | €94.88 Million ≈ $110.93 Million |
€17.57 Million ≈ $20.54 Million |
0.185x | -55.57% |
| 2005-12-31 | €82.87 Million ≈ $96.88 Million |
€34.54 Million ≈ $40.38 Million |
0.417x | +372.91% |
| 2004-12-31 | €102.54 Million ≈ $119.88 Million |
€9.04 Million ≈ $10.57 Million |
0.088x | -- |
About Fagron NV
Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, patients, and worldwide. It operates through three segments: Essentials, Brands, and Compounding Services. The company's products include DiluCap, a line of excipients to compound every capsule formulation; DiluTab, for Cardiology and Primary care application; Imuno TF Com… Read more